TrialClinical and translational science2025

First-In-Human, Randomized, Placebo-Controlled, SAD and MAD Trial to Evaluate Safety, Tolerability, and PK/PD Modeling of Potravitug in Healthy Adults.

Marcus May et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.